Association between type A or type B anti-β2GPI antibodies and (β2GPI-dependent) LAC activity and thrombosis
. | Total population, N = 198 . | . | . | ||
|---|---|---|---|---|---|
| . | Anti-β2GPI IgG present, n = 52 . | . | Anti-β2GPI IgG not present, n = 146 . | ||
. | Type A, n = 30 . | Type B, n = 22 . | . | ||
| LAC, n = 63 | 28 | 6 | 29 | ||
| β2GPI-dependent LAC, n = 25 | 23 | 2 | 0 | ||
| Thrombosis, n = 60 | 25 | 7 | 28 | ||
| Odds ratio for thrombosis | 18.9 | 1.1 | NA | ||
| 95% CI | 53.2-6.8 | 2.8-0.4 | NA | ||
. | Total population, N = 198 . | . | . | ||
|---|---|---|---|---|---|
| . | Anti-β2GPI IgG present, n = 52 . | . | Anti-β2GPI IgG not present, n = 146 . | ||
. | Type A, n = 30 . | Type B, n = 22 . | . | ||
| LAC, n = 63 | 28 | 6 | 29 | ||
| β2GPI-dependent LAC, n = 25 | 23 | 2 | 0 | ||
| Thrombosis, n = 60 | 25 | 7 | 28 | ||
| Odds ratio for thrombosis | 18.9 | 1.1 | NA | ||
| 95% CI | 53.2-6.8 | 2.8-0.4 | NA | ||
Numbers are depicted as absolute number of patients.
NA indicates not applicable.